摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2,4-Dimethoxy-phenyl)-4-hydroxy-4-methyl-6-oxo-cyclohexan-1,3-dicarbonsaeure-diaethylester | 64670-39-9

中文名称
——
中文别名
——
英文名称
2-(2,4-Dimethoxy-phenyl)-4-hydroxy-4-methyl-6-oxo-cyclohexan-1,3-dicarbonsaeure-diaethylester
英文别名
2-(3,4-dimethoxy-phenyl)-4-hydroxy-4-methyl-6-oxo-cyclohexane-1,3-dicarboxylic acid diethyl ester;2-(3,4-Dimethoxy-phenyl)-4-hydroxy-4-methyl-6-oxo-cyclohexan-1,3-dicarbonsaeure-diaethylester;4-Hydroxy-6-oxo-4-methyl-2-(3,4-dimethoxy-phenyl)-cyclohexan-dicarbonsaeure-(1,3)-diaethylester;Diethyl 2-(3,4-dimethoxyphenyl)-4-hydroxy-4-methyl-6-oxocyclohexane-1,3-dicarboxylate
2-(2,4-Dimethoxy-phenyl)-4-hydroxy-4-methyl-6-oxo-cyclohexan-1,3-dicarbonsaeure-diaethylester化学式
CAS
64670-39-9
化学式
C21H28O8
mdl
MFCD00718104
分子量
408.449
InChiKey
SSFQCYJOBBZRIP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    138.5-140.5 °C
  • 沸点:
    531.3±50.0 °C(Predicted)
  • 密度:
    1.205±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    29
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    108
  • 氢给体数:
    1
  • 氢受体数:
    8

反应信息

点击查看最新优质反应信息

文献信息

  • Effect of Aryl-Cyclohexanones and their Derivatives on Macrophage Polarization In Vitro
    作者:Tainá L. Lubschinski、Luiz A. E. Pollo、Eduarda T. B. Mohr、Julia S. da Rosa、Luigi A. Nardino、Louis P. Sandjo、Maique W. Biavatti、Eduardo M. Dalmarco
    DOI:10.1007/s10753-022-01646-9
    日期:2022.8
    Macrophages are critical in both tissue homeostasis and inflammation, and shifts in their polarization have been indicated as pivotal for the resolution of inflammatory processes. Inflammation is a complex and necessary component of the immune response to stimuli that are harmful to host homeostasis and is regulated by cellular and molecular events that remain a source of ongoing investigation. Among the compounds studied that have potential against autoimmune and inflammatory diseases, cannabinoids are currently highlighted. In this work, nineteen aryl-cyclohexanones diesters and their derivatives were synthesized based on the aryl-cyclohexane skeleton of phytocannabinoids, such as cannabidiol (CBD), and were evaluated for their anti-inflammatory and macrophage polarization potential. The results showed that Compound 4 inhibited the production of nitric oxide in RAW 264.7 macrophages. Furthermore, it reduced the levels of pro-inflammatory cytokines IL-12p70, TNF-α, IFN-γ, MCP-1, and IL-6 while, at the same time, was able to increase the production of anti-inflammatory cytokines IL-4, IL-10, and IL-13. Compound 4 also reduced macrophage apoptosis, increased the expression of the CD206 (mannose receptor) and at the same time, decreased the expression of CD284 (TLR-4 receptor) on the surface of these cells. Finally, it increased the phagocytic capacity and inhibited the phosphorylation of the p65 of NF-kβ. In conclusion, Compound 4, identified as diethyl-4-hydroxy-2-(4-methoxyphenyl)-4-methyl-6-oxocyclohexane-1–3-dicarboxylate, showed significant anti-inflammatory effect, while demonstrating the ability to transform phenotypically macrophages from the M1 phenotype (pro-inflammatory) to the M2 phenotype (anti-inflammatory). This led us to hypothesize that the main mechanism of anti-inflammatory effect of this molecule is linked to its immune modulation capacity.
    巨噬细胞在组织稳态和炎症过程中都起着至关重要的作用,其极化的变化被认为是解决炎症过程的关键。炎症是免疫反应的一个复杂而必要的组成部分,它针对的是对宿主稳态有害的刺激,并受到细胞和分子事件的调节,而这些事件仍是研究的一个来源。在已研究的具有抗自身免疫性和炎症性疾病潜力的化合物中,大麻素是目前研究的重点。本研究以大麻二酚(CBD)等植物大麻素的芳基环己烷骨架为基础,合成了 19 种芳基环己酮二酯及其衍生物,并对其抗炎和巨噬细胞极化潜力进行了评估。结果表明,化合物 4 能抑制 RAW 264.7 巨噬细胞产生一氧化氮。此外,它还能降低促炎细胞因子 IL-12p70、TNF-α、IFN-γ、MCP-1 和 IL-6 的水平,同时还能增加抗炎细胞因子 IL-4、IL-10 和 IL-13 的产生。化合物 4 还能减少巨噬细胞凋亡,增加这些细胞表面 CD206(甘露糖受体)的表达,同时减少 CD284(TLR-4 受体)的表达。最后,它还提高了吞噬能力,抑制了 NF-kβ 的 p65 的磷酸化。总之,被鉴定为二乙基-4-羟基-2-(4-甲氧基苯基)-4-甲基-6-氧代环己烷-1-3-二甲酸酯的化合物 4 显示出了显著的抗炎效果,同时还显示出了将巨噬细胞从 M1 表型(促炎)转化为 M2 表型(抗炎)的能力。由此我们推测,该分子抗炎作用的主要机制与其免疫调节能力有关。
  • Aromatization Studies. IV. Palladium Dehydrogenation of Arylcyclohexenones to Phenols
    作者:E. C. Horning、M. G. Horning
    DOI:10.1021/ja01198a035
    日期:1947.6
  • THE CHEMOTHERAPY OF CANCER. II. SOME ARYL-SUBSTITUTED ALKOXYMETHYLENE CYCLOHEXENONES<sup>1, 2</sup>
    作者:KENNETH N. CAMPBELL、ALBERT SCHRAGE、BARBARA K. CAMPBELL
    DOI:10.1021/jo01152a002
    日期:1950.11
  • LAL B.; BHADURI A. P., INDIAN J. CHEM. <IJOC-P>, 1977, B 15, NO 4, 359-363
    作者:LAL B.、 BHADURI A. P.
    DOI:——
    日期:——
  • Chemistry of the podocarpaceae—XV
    作者:B.R. Davis、W.B. Watkins
    DOI:10.1016/0040-4020(68)88118-9
    日期:1968.1
    The conversion of the diterpenoid resin acid, podocarpic acid, into a tetracyclic system possessing a 5-membered ring D is described. The unsubstituted ring with a CO group at C-151 was prepared from the 13-(2′-carboxyethyl) derivative III (R  CH2CH2CO2H) in fair yield, but attempted cyclization of compounds possessing a 1′-substituted-2′-carboxyethyl side chain at C-13 was unsuccessful. The C-17
    描述了将二萜树脂酸,罗汉果酸转化为具有5元环D的四环体系。由13-(2'-羧乙基)衍生物III(RCH 2 CH 2 CO 2 H)以合理的产率制备了在C-15 1处带有CO基团的未取代环,但尝试将具有1'的化合物环化C-13的-取代的2'-羧乙基侧链不成功。从13-丙烯酰基化合物以低收率获得C-17酮,但从13-巴豆酰基化合物根本得不到。描述了一些涉及苯甲醚衍生物的模型实验。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐